ADR120S, Inc. (3750) Other
Market cap
¥7.4B
P/E ratio
102.5x
Saitori Cell Research Institute develops regenerative cell therapies and medical devices while also investing in real estate projects through seven subsidiaries.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | 0.8 | -6.8 | 11 | 9.2 | 3.1 | -4.4 | -0.5 | -2.2 | 6.9 | -29.7 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 47 | 28 | 31 | 34 | 19 | 10 | 5 | 5 | 53 | 51 | 63 | 64 | 16 | 10 |